The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Prediction of Human Drug Clearance from in Vitro and Preclinical Data Using Physiologically Based and Empirical Approaches
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some suggestions for measuring predictive performance
Sheiner, L. B., & Beal, S. L. (1981) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01060893 · Cited by 1,617
Obach, R. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14938-0 · Cited by 1,232
The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data
Obach, R. S., Baxter, J. G., Liston, T. E., Silber, B. M., Jones, B. C., Macintyre, F., Rance, D. J., & Wastall, P. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36999-x · Cited by 987
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925 · cited 3×
“In vitro drug metabolism kinetic parameters can provide an estimate of in vivo intrinsic clearance (CLint) for the whole liver by the use of a scaling factor (SF) and subsequently hepatic clearance (CLh) with the use of a liver model (1).”
BackgroundMethodPang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data
Sun, K. (2005) · Chinese New Drugs Journal · Cited by 762
Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
Boxenbaum, H. (1982) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062336 · Cited by 648 · cited 2×
“CLint,h,in vivo = CLint,h,in vitro × PB-SF × CLint,r,in vivo CLint,r,in vitro (4) where CLint,r,in vitro (ml min −1 kg) was calculated using the scaling factor of 500 (mg protein/250 g) (2).”
MethodBischoff, K. B., Dedrick, R. L., Zaharko, D. S., & Longstreth, J. A. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600803 · Cited by 480
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479
Dedrick, R. L. (1973) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059667 · Cited by 397
Houston, J. B., & Kenworthy, K. E. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15358-5 · Cited by 389
Self-citationIs the Role of the Small Intestine in First-Pass Metabolism Overemphasized?
Lin, J. H., Chiba, M., & Baillie, T. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01402-9 · Cited by 352
Characterization of Human Small Intestinal Cytochromes P-450
Zhang, Q.-Y., Dunbar, D., Ostrowska, A., Zeisloft, S., Yang, J., & Kaminsky, L. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15229-4 · Cited by 343
(2001) · PubMed · Cited by 316
Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver Slices
Brian Houston, J., & Carlile, D. J. (1997) · Drug Metabolism Reviews · doi:10.3109/03602539709002237 · Cited by 306
Poulin, P., & Theil, F.-P. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10128 · Cited by 303
Interspecies Scaling: Predicting Clearance of Drugs in Humans. Three Different Approaches
Mahmood, I., & Balian, J. D. (1996) · Xenobiotica · doi:10.3109/00498259609052491 · Cited by 257
In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance
Soars, M. G., Burchell, B., & Riley, R. J. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.382 · Cited by 228
Ito, K., & Houston, J. B. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026429.12114.7d · Cited by 224
Self-citationLave, T. H., Dupin, S., Schmitt, C., Chou, R. C., Jaeck, D., & Coassolo, P. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960440h · Cited by 184
Engel, G., Hofmann, U., Heidemann, H., Cosme, J., & Eichelbaum, M. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90001-6 · Cited by 176
Lin, J. H., Chiba, M., Balani, S. K., Chen, I., Kwei, G. Y., Vastag, K., & Nishime, J. A. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08414-4 · Cited by 153
Chiba, M., Hensleigh, M., & Lin, J. H. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00100-7 · Cited by 134
Microsomal prediction of in vivo clearance of CYP2C9 substrates in humans
Carlile, D. J., Hakooz, N., Bayliss, M. K., & Houston, J. B. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00935.x · Cited by 126
Self-citationDisposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.
Balani, S. K., Woolf, E., Hoagland, V. D., Sturgill, M. G., Deutsch, P., Yeh, K. C., & Lin, J. H. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08479-x · Cited by 99
Prediction of Hepatic Metabolic Clearance: Comparison and Assessment of Prediction Models
Zuegge, J., Schneider, G., Coassolo, P., & Lav??, T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00006 · Cited by 92
Iwatsubo, T., Suzuki, H., & Sugiyama, Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37073-9 · Cited by 70
Chiou, W. L., Robbie, G. J., Chung, S. M., Wu, T., & Ma, C. (1998) · Pharmaceutical Research · doi:10.1023/a:1011974226596 · Cited by 61
Pollack, G. M., Brouwer, K. L. R., Demby, K. B., & Jones, J. A. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07605-6 · Cited by 37
Interspecies Metabolism and Pharmacokinetic Scaling of Theophylline Disposition
Gaspari, F., & Bonati, M. R. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539009041084 · Cited by 30
Jones, B. D., Ching, M. S., Smallwood, R. A., & Morgan, D. J. (1985) · Hepatology · doi:10.1002/hep.1840050411 · Cited by 29
Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.
Eriksson, U. G., Lundahl, J., Bäärnhielm, C., et al. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08966-4 · Cited by 25
Induction of propranolol metabolism by the azo dye sudan III in rats
Ishida, R., Obara, S., Masubuchi, Y., Narimatsu, S., Fujita, S., & Suzuki, T. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90332-d · Cited by 15
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Self-citationHosea, N. A., Collard, W. T., Cole, S., Maurer, T. S., Fang, R. X., Jones, H., Kakar, S. M., Nakai, Y., Smith, B. J., Webster, R., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009333209 · Cited by 300
Gertz, M., Harrison, A., Houston, J. B., & Galetin, A. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.032649 · Cited by 297
Self-citationHayes' Principles and Methods of Toxicology
(2014) · CRC Press eBooks · doi:10.1201/b17359 · Cited by 280
Metadata
- Authors
- Ito, K., & Houston, J. B.
- Venue
- Pharmaceutical Research
- Published
- 2005-01
- Volume
- 22
- Issue
- 1
- Pages
- 103-112
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2171671443
- Cited by
- 260
- References
- 34
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.